Foghorn Therapeutics Inc. (FHTX) Misses Q1 EPS by 11c
Tweet
Share
E-mailGet Alerts FHTX Hot Sheet
Join SI Premium – FREE
Foghorn Therapeutics Inc. (NASDAQ: FHTX) reported Q1 EPS of ($0.30), $0.11 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $5.95 million versus the consensus estimate of $5.95 million.
For earnings history and earnings-related data on Foghorn Therapeutics Inc. (FHTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Lockheed Martin wins $83 million Army missile contract
- Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
